Labcorp Holdings Inc.
LHNYSEHealthcare● Active
$262.01
$-3.14(-1.18%)
Market Cap$21.5B
P/E Ratio—
52W High$293.72
52W Low$241.81
Labcorp Holdings Inc.（LH）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LH · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.88B | $0.75B | $0.38B | $1.00B | $2.38B |
| Depreciation & Amort. | $0.68B | $0.64B | $0.58B | $0.54B | $0.58B |
| Stock-Based Comp. | $0.13B | $0.12B | $0.13B | $0.12B | $0.13B |
| Change in Working Capital | ($0.53B) | ($0.15B) | ($0.36B) | ($0.60B) | ($0.26B) |
| Net Cash from Operations | $1.64B | $1.59B | $1.33B | $1.96B | $3.11B |
| Investing Activities | |||||
| Capital Expenditure | ($0.43B) | ($0.49B) | ($0.45B) | ($0.48B) | ($0.46B) |
| Purchases of Investments | ($0.19B) | ($0.06B) | ($0.03B) | ($0.02B) | ($0.03B) |
| Sales of Investments | $0.01B | $0.00B | $0.01B | $0.01B | $0.01B |
| Net Cash from Investing | ($1.19B) | ($1.37B) | ($1.17B) | ($1.65B) | ($0.88B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.45B) | ($0.25B) | ($1.04B) | ($1.15B) | ($1.72B) |
| Dividends Paid | ($0.24B) | ($0.24B) | ($0.25B) | ($0.20B) | $0.00B |
| Debt Issued / Repaid | ($0.78B) | $1.00B | ($0.30B) | $0.00B | ($0.38B) |
| Net Cash from Financing | ($1.46B) | $0.78B | ($0.06B) | ($1.32B) | ($2.07B) |
| Free Cash Flow | |||||
| Free Cash Flow | $1.21B | $1.10B | $0.87B | $1.47B | $2.65B |
| FCF Margin %(computed) | 8.64% | 8.42% | 7.19% | 12.42% | 20.17% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Labcorp Holdings Inc.
关于Labcorp Holdings Inc.（LH）现金流量表
Labcorp Holdings Inc. 2025财年经营活动现金流$1.64B，自由现金流$1.21B（FCF利润率8.64%），资本支出($0.43B)。
常见问题
LH · 4 问Labcorp Holdings Inc. 2025财年自由现金流$1.21B，同比up10.0%。
LH free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10